AI-provider VideaHealth announced the U.S. Food and Drug Administration (FDA) has issued clearance for Videa Caries Assist, an AI-powered dental caries (cavity) detection algorithm. VideaHealth surpassed the FDA’s exacting efficacy requirements by significantly aiding the analysis of radiographs instantly from the dentist’s chair.
In the FDA trial, the number of missed caries was 43% lower for dentists using Videa’s AI. Notably, the dentists using Videa’s AI also experienced a 15% average reduction in erroneous detections of caries lesions. All dentists in the trial, regardless of experience level, encountered caries detection capability improvements. These detection performance improvements enable more accurate diagnoses, better preventative care and substantial cost savings for patients by reducing unnecessary invasive treatments. A joint study with VideaHealth partner Heartland Dental revealed similar impacts on diagnostic improvements and treatment planning.
Dataset
VideaHealth is operating in a a market that has remained largely unchanged for the past 30 years. The company’s solution is built upon the Videa Factory, which houses a diverse dataset with over 100 million data points from dental service organizations (DSOs), insurance companies, clearinghouses and universities. This helps the VideaHealth algorithms remain impartial and more fully represent the diversity of the U.S. population.
Florian Hillen, leading industry AI researcher and founder and CEO of VideaHealth, said, “Our biggest priority as a team is ensuring that our solution is effective across diverse patient populations and helps dentists deliver the most accurate diagnoses. This paves the way for more appropriate dental treatment recommendations and the opportunity for dentists to foster deeper patient engagement.”
